CLL/SLL Clinical Trials in Zhengzhou, Henan
2 recruitingZhengzhou, Henan, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Global Trial in APG2575 for Patients With CLL/SLL
CLL/SLL
Ascentage Pharma Group Inc.400 enrolled135 locationsNCT06104566
Recruiting
Phase 3
A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
CLL/SLL
Ascentage Pharma Group Inc.344 enrolled6 locationsNCT06319456